Data from the literature have shown that CFRD and type 2 diabetes mellitus (T2DM) have overlapping etiology and pathophysiological mechanisms, mainly represented by impaired pancreatic β cells with decreased insulin secretion, rather than decreased insulin sensitivity. This evidence concerns the gene INS and diabetes mellitus.